The CRUK CoL Centre AstraZeneca (AZ) Clinical Research Training Fellowship
Applications for a CRUK CoL Centre AstraZeneca fellowship commencing in January 2021 are now open. This is a unique multidisciplinary and collaborative training opportunity for any clinician who is interested in carrying out research in cancer biotherapeutics.
The successful clinical research training fellow will be based within the group of a CoL Centre primary supervisor and will work in close collaboration with AZ scientists. He /she will also spend at least 2 months on a research placement with AZ in Cambridge, and will benefit from additional oversight and advice from a thesis committee that will include AZ researchers.
The fellow appointed will follow a three-year version of the CRUK CoL PhD training programme, which provides a firm foundation for clinicians with a future academic career path in mind. He/she will follow a customised training plan, developed in collaboration with their supervisors and tailored to their background and project requirements. Trainees will benefit from multi-disciplinary scientific and cohort-building activities, plus the Centre’s networking workshops and conferences.
We are looking for talented and motivated clinicians who are passionate about research, have a strong academic track record and hold full GMC registration or equivalent. These are full-time research positions with limited participation in clinical activities. They are fully funded for three years, and PhD registration will be at the primary supervisor’s university. Successful candidates will receive a salary commensurate with their current experience, paid on the clinical academic scale.
Due to funding restrictions only UK / EU nationals will be eligible to apply for this fellowship
Submitting your application
Applications must be submitted through the Crick’s online academic recruitment system.
Before beginning an application, you should read the information on this page and the “completing the application form” page. You should also find out about the projects being offered to start in January 2021 and their supervisors via the specific project pages (see below).
You must complete all required sections of the application form in full.
- Your application must be submitted by the deadline: 12noon 14 August 2020
- We will not accept late applications.
- We should receive your references by 17 August 2020. Your application may still be considered if references are not received by this deadline. However, no applicant will be invited to interview unless references have been received.
- You will find out if you have been invited to interview for the programme by 26 August 2020.
Interviews will take place remotely via zoom in the week commencing 01 September 2020. During the interview, candidates will be interviewed by a panel of CRUK CoL faculty, and AZ representatives. Please note that only one fellowship will be awarded to the best applicant based on information submitted on the application form, references and performance during the interview.
Project 1: Innovative computational approaches to understand and counteract mechanisms of radiation-induced DNA damage response. Primary Supervisor: Prof Jasmin Fisher, UCL Cancer Institute, AZ leads: Dr Mark O’Connor, and Dr Krishna Bulusu
Project 2: TGF-beta family members as potential therapeutic targets in pancreatic cancer. Supervisors: Dr Caroline Hill, The Francis Crick Institute and Dr Debashis Sarker, Kings College London, and Guys and St Thomas’ Hospital, AZ lead: Dr Robert Wilkinson
Project 3: Understanding DNA repair inhibitor sensitivity, resistance and replication stress in breast cancer via longitudinal profiling and use of patient derived models. Supervisor: Prof Andrew Tutt, Kings’s College London, AZ lead: Dr Natasha Lukashchuk, Translational Medicine, AstraZeneca, Cambridge